Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

Justin Taylor(Memorial Sloan Kettering Cancer Center), Mark T.A. Donoghue(Molecular Oncology (United States)), Caleb Ho, Kseniya Petrova‐Drus, Hikmat Al‐Ahmadie, Samuel A. Funt(Spanish Oncology Genitourinary Group), Yanming Zhang, Umut Aypar, Pavitra Rao(Molecular Oncology (United States)), Shweta S. Chavan(Molecular Oncology (United States)), Michael Haddadin(Memorial Sloan Kettering Cancer Center), Roni Tamari(Bone Marrow Foundation), Sergio Giralt(Bone Marrow Foundation), Martin S. Tallman, Raajit K. Rampal, Priscilla Baez(Memorial Sloan Kettering Cancer Center), Rajya Kappagantula(Memorial Sloan Kettering Cancer Center), Satyajit Kosuri(Bone Marrow Foundation), Ahmet Doǧan, Satish K. Tickoo, Victor E. Reuter, George J. Bosl(Spanish Oncology Genitourinary Group), Christine A. Iacobuzio–Donahue(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Barry S. Taylor(Memorial Sloan Kettering Cancer Center), Darren R. Feldman(Spanish Oncology Genitourinary Group), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center)
Journal of Clinical Investigation
September 8, 2020
Cited by 54Open Access
Full Text

Abstract

Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15 and 40. Although most patients are cured, those with disease arising in the mediastinum have distinctly poor outcomes. One in every 17 patients with primary mediastinal nonseminomatous GCTs develop an incurable hematologic malignancy and prior data intriguingly suggest a clonal relationship exists between hematologic malignancies and GCTs in these cases. To date, however, the precise clonal relationship between GCTs and the diverse additional somatic malignancies arising in such individuals have not been determined. Here, we traced the clonal evolution and characterized the genetic features of each neoplasm from a cohort of 15 patients with GCTs and associated hematologic malignancies. We discovered that GCTs and hematologic malignancies developing in such individuals evolved from a common shared precursor, nearly all of which harbored allelically imbalanced p53 and/or RAS pathway mutations. Hematologic malignancies arising in this setting genetically resembled mediastinal GCTs rather than de novo myeloid neoplasms. Our findings argue that this scenario represents a unique clinical syndrome, distinct from de novo GCTs or hematologic malignancies, initiated by an ancestral precursor that gives rise to the parallel evolution of GCTs and blood cancers in these patients.


Related Papers

No related papers found

Powered by citation graph analysis